Documents to download

There are multiple areas where the United Kingdom’s departure from the European Union may affect how antimicrobial resistance (AMR) is addressed. AMR is a global health issue, with strategic coordination occurring at several levels to address the issue—from the World Health Organisation, to the EU, and in the UK’s national health strategy. The World Bank has predicted that, globally, AMR will lead to increases in morbidity and mortality, increase the burden on healthcare systems, increase extreme poverty, and that it could inflict heavy losses on the global economy.

Access to the latest effective antibiotics is important for the treatment of patients and the mitigation of resistance development, and may be affected by changes in the development and regulation of new medicines—both of which pose particular challenges with regards to antimicrobials, and especially antibiotics. The UK has been heavily involved in medicine development and regulation in the EU, and the European Medicines Agency is currently based in London (though it will relocate to Amsterdam following the UK’s departure from the EU). The UK Government has stated that it wishes to continue to participate in the European Medicines Agency under new arrangements that recognise the UK will not be a member state. 

Trade agreements regarding food and agriculture have been highlighted by commentators as presenting both risk and opportunity in the context of AMR. Responsible antimicrobial use on farms is a key issue for AMR, and whether the UK maintains or reduces regulation in this area may be dependent on future trading arrangements. Michael Gove, Secretary of State for Environment, Food, and Rural Affairs, has stated there should be no compromise on animal welfare and environmental standards, and that the high levels of antibiotic use in agriculture in the United States are a concern. The UK Government has argued that being outside the EU Common Agricultural Policy would provide the freedom to apply higher animal welfare standards.

A key part of the EU’s strategy against AMR is the development of epidemiological surveillance infrastructure across the member states. The UK Government has proposed continued close collaboration with the European Centre for Disease Prevention and Control including access to alert systems, databases, and networks.


Documents to download

Related posts

  • The UK legislation for the safety and quality of blood, organs, tissue and cells (including reproductive cells) is based on EU law. The European Union Withdrawal Act 2018 ensures that EU-derived domestic legislation will continue to have effect after the end of the transition period. In 2019, regulations were introduced to ensure that UK legislation in this area could function effectively after the transition period. However, Northern Ireland will remain subject to relevant EU laws as a result of the Ireland/Northern Ireland Protocol. This article looks at four statutory instruments that would amend the 2019 regulations and enable Northern Ireland to continue to meet EU law.

  • The draft Flags (Northern Ireland) (Amendment) (No. 2) Regulations 2020 would make changes to regulations governing the flying of flags on government buildings in Northern Ireland. They would remove one building from the list of sites where the Union flag must be flown and add two others. They would also add the birthdays of the Duke and Duchess of Cambridge, and of the Duchess of Cornwall, to the dates on which the Union flag must be flown.

  • The United Kingdom Internal Market Bill seeks to ensure unfettered access to the UK internal market for “qualifying Northern Ireland goods”. On 7 October 2020, the Government published the draft Definition of Qualifying Northern Ireland Goods (EU Exit) Regulations 2020. They contain the definition of “qualifying Northern Ireland goods” that will apply to the bill. This article explains the background to the regulations, and why the Government also intends to introduce further legislation in this area.